A patient in Sweden has been admitted to hospital with a suspected case of Ebola, a highly infectious and potentially fatal disease, health care officials said Friday.
Jan 4, 2019
1
4
A new study by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSVΔG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic ...
Feb 8, 2022
1
407
Researchers from LLNL and three other institutions have assisted a Bay Area biomedical company in advancing its Ebola virus detection test for use.
May 29, 2015
0
13
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...
The World Health Organization said Monday its experts will meet this week to determine whether an Ebola outbreak in eastern Democratic Republic of Congo constitutes a global health emergency.
Oct 15, 2018
0
43
Ebola survivors can relapse and trigger outbreaks at least five years after infection, and long-term follow-up of former patients is needed to prevent devastating flare-ups, according to new research.
Sep 15, 2021
0
199
With a mortality rate of up to 88 percent, Marburg virus can rip through a community in days. In 2005, an outbreak of Marburg virus struck a pediatric ward in the country of Angola. With no treatment available, doctors struggled ...
Jan 10, 2018
0
41
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues have discovered that a single monoclonal antibody—a protein that attacks viruses—isolated ...
Feb 25, 2016
0
47
Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium. In a Viewpoint ...
Aug 11, 2018
0
15
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers ...
Jan 30, 2023
0
59
